D. Beshkov

HIV‑1 molecular epidemiology in the Balkans: a melting pot for high genetic diversity.

M. Poljak, J. Minárovits, D. Otelea, 2012, AIDS reviews.

Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity.

A. Wensing, M. Nikolova, W. Switzer, 2015, The Journal of antimicrobial chemotherapy.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Jan Albert, Kirsi Liitsola, Mario Poljak, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

Klaus Korn, Kristof Theys, Anne-Mieke Vandamme, 2013, Retrovirology.

Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group

M. Poljak, R. Paredes, K. Korn, 2014, PloS one.

The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries.

Tulio de Oliveira, Maureen M Goodenow, Marco Salemi, 2008, AIDS research and human retroviruses.

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

M. Poljak, A. Wensing, R. Paredes, 2014, BMC Infectious Diseases.

Limited cross-border infections in patients newly diagnosed with HIV in Europe

M. Poljak, A. Wensing, R. Paredes, 2013, Retrovirology.

Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria.

F. Ceccherini‐Silberstein, M. Ciccozzi, G. Rezza, 2008, AIDS research and human retroviruses.

Detailed Molecular Epidemiologic Characterization of HIV-1 Infection in Bulgaria Reveals Broad Diversity and Evolving Phylodynamics

W. Switzer, D. Paraskevis, A. Shankar, 2013, PloS one.